Cat. # 10415A/B
- Target Name: Human CD20 N-terminus synthetic peptide (CMQSGPKPLFRRMSS)
- Antigen: Purified CD25
- Clone: 4-6H:2C
- Application: WB, IHC
- Entrez Gene ID: 931
Recommended antibody concentration (the optimal concentration should be determined empirically)
- Western blot: 1 µg/mL
- IHC: For FFPE tissues after heat-induced antigen retrieval, 1 µg/mL
Lyophilized: stable 5 years at 2–8°C. In solution: stable 2 years at –20°C.
Lyophilized from an antibody solution containing 1% BSA in PBS and 0.05% NaN3. To use, reconstitute in H2O (final concentration, 100 µg/mL).
MS4A1, B1, S7, Bp35, CVID5, MS4A2, LEU-16
- Mishima, Y., et al. (2011) The identification of irreversible rituximab-resistant lymphoma caused by CD20 gene mutations. Blood Cancer J. 1(4):e15.
For research use only. Not for use in diagnostic procedures.